Pod Insights Pharmacy Podcast Network From Constraint to Catalyst: Interest Rates and the LTC Market | Framework Focus About this episode In this episode of FrameworkFocus, we explore how the long-term care (LTC) market has evolved from the pre-pandemic boom through COVID-19’s sharp disruption to today’s near-recovery. Jason Yablinsky, CFO at SoftWriters, unpacks how shifting interest rates, housing liquidity, and the coming wave of Baby Boomer demand are reshaping the industry’s trajectory. Tune in to learn why today’s financial constraints may soon become tomorrow’s catalysts for growth.
Transcript 0:05 Speaker 00 You are listening to the global network of podcasters dedicated to the pharmacy profession. Welcome to the pharmacy podcast network.
0:31 Speaker 01 You are listening to Framework Focus, the podcast that explores trends, innovations, and insights in the long-term care pharmacy industry. Join us as we connect the entire LTC ecosystem.
0:43 Speaker 02 I get to share some insights today from a chief financial officer. These are the people that hate me the most because I should never be in charge of any budgeting or any kind of money. Jason, do not let me have the money. You control.
1:00 Speaker 03 But how are you? I'm doing great. Yeah. And as a marketer, we talked a little bit before the podcast and just some of the great work that you're doing with with some of the pharmacies. I can certainly relate to the the marketing budget requests that often come to my desk. But yeah, thanks so much for having me. This is my first podcast episode on on your network. Really excited to be here and excited to to share some of what we're seeing in the long-term care industry.
1:32 Speaker 02 We're excited to have you here. When we were in the green room, I was talking to Jason about some of the lack of content throughout different podcasts that are available. I enjoy other podcast networks like Becker's Health. I just think they're a wonderful publication. We've actually been on each other's shows before and the wide audience that they grab the attention of. One of the audiences that you and I are so focused on and is so important to the to our publication and our coverage of our profession is long-term care pharmacy. And as you know, I shared before we started recording. I was very proud that my first entry into pharmacy was through softwriters.
2:15 Speaker 02 And I was the first sales and business development rep to drive and help pharmacies understand the difference between the DOS-based systems back in the day that had no workflow. They had, it was, it was prescription-driven by the individual patient. It wasn't batch, it wasn't doing massive work behind the scenes in order to make long-term care pharmacy, which is so different than other sectors. So having the intelligence of a CFO to kind of dive into today's subject from that long-term care pharmacy position and in part of that industry, from constraint to catalyst, interest rates and the long-term care market.
2:59 Speaker 02 Jason, I'm looking forward to this one. So take us, take us through, right out of the gate, you know, what's the state of the nation of long-term care market and, and, you know, what did it look like before the pandemic? And pandemic kind of wrecked a lot of things, so it, it made its adjustment. But where are we at right now?
3:19 Speaker 03 Yeah, so I hate to take everybody back to the pandemic, but we, we obviously follow the long-term care industry quite closely, right? Because it really determines our strategy, make, make sure that we're sort of on the right path with our strategy to ultimately grow and, and build a sustainable business for, for decades to come.
3:44 Speaker 03 But this sort of storyline is very interesting and ultimately I'll get to the point, but I believe that interest rates are going to produce or, or a reduction in, in interest rates with the Fed will produce a, a wave of growth in our industry. And I'll, I'll get to sort of the details of that. But just going back in 2019, before the pandemic, things were, were pretty strong. We were in a good place. Construction of new facilities was healthy, interest rates were favorable. We look at occupancy, which is really important. I think that the unit of economics or unit of measure that's most important in our industry is the number of patients coming in. And that occupancy was near 90%, so about 87, 88% right before the pandemic hit.
4:32 Speaker 03 Then, of course, in late Q1, early Q2 of 2020, the pandemic hit and ultimately dropped pretty immediately. The occupancy from that 87, 88% to about 78%. And that represented actually a pretty large number of patients that exited long-term care facilities. We estimate about 250,000 to 300,000 patients from the about 3 million licensed beds in the US. And that it triggered a supply and demand dislocation. Demand knows that, right? Because families wanted their loved ones at home. Construction slowed because demand dropped.
5:14 Speaker 03 As we all know, it took quite a few years to get back to the occupancy levels that we saw before the pandemic. We all remember material costs rose. I do quite a few house projects. Two by fours doubled in price. And of course, borrowing became pricier because interest rates were rising. Right? So all these things ultimately led to really first facility entrance fees fell, right? Law of supply and demand to try to bring residents back. And it took, you know, 12, 18 months even for facilities to figure out what is the new world going to be like? And I think, you know, over the course of those occupancy improvements, the prices came down.
5:57 Speaker 03 Further for our customers and for the long-term care facilities, staffing became a problem throughout the pandemic. I think a lot of those workers went to the gig economy, right? They could Uber or Lyft or DoorDash and they'd have more flexibility. They have less stress. They sometimes get paid more, right? So all these became a challenge for our industry. And for us as a company, I think we did respond quite quickly and we did develop a vaccine solution in literally a couple of months to help our customers really dispense and report the vaccines to the state agencies.
6:40 Speaker 03 So I think we navigated it as well as we could have and had the pleasure of being here throughout that period on the FPNA or finance side of the business, right? It's the first person that everybody looks to, right? So you have to be able to instill confidence and forecast the business and have the right indicators in the business to understand when do you pause? When do you cut if necessary? Fortunately for us, we didn't have to make cuts. We paused for a period of time. And then on the other side of the pandemic, I think one of the things that was most important to us is step on the gas whenever it was appropriate to step on the gas.
7:22 Speaker 03 So we had all these mechanisms in place and when we started to see recovery, we invested and really maximized what we called exit velocity, right? Making sure we're not robbing the business of potential opportunity to grow and, you know, build new products for our customers. So certainly dynamic and challenging time, but it positioned us to adjust very swiftly as occupancy began to rebound.
7:52 Speaker 02 I was excited to hear you in your opening, Jason, mention growth because I'm hearing that from multiple sectors of healthcare and inside pharmacy. We're hearing that from a lot of technology companies who are investing in AIs and accelerant to many things that they're taking an analysis of, including drug shortages and how to avoid it and what trends are happening year after year with the cold season or whatever it is that makes those flux really starting to dial in. So when you said growth and you said interest rates, that piqued my interest.
8:34 Speaker 02 I really want for the listeners to understand your perspective because I'm a glass half full kind of guy. I want, I want us to hit some growth and I, and I want to see pharmacies thriving.
8:48 Speaker 03 Yeah, absolutely. And, you know, certainly we'll get to sort of how I believe there's going to be this, I call it a snowball of growth that I expect in the next, say, you know, midterm, five to seven years. But if you fast forward to today, it took nearly five years to get back from that 78% occupancy to where it is now, about 88%, which is right where it was pre-pandemic. And just to touch a little bit more on the market, that's wonderful. Again, the unit economic is the patient, right? So if there's demand there, then ultimately that will help grow our network. But on the other hand, we're seeing facility construction
9:33 Speaker 03 at its weakest pace since 2014. And because that inventory growth has really fell behind, that that rising demand for senior housing, it's been driving up that percentage. If you think of occupancy, the calculation is the number of beds available as the denominator and the number of patients in the beds, right? So if you have baby boomers aging, right, you're getting more patients. But if the denominator and the number of beds stays flat or potentially even declines, then you're going to have a much higher occupancy percentage. So it's good news. I think it's a shorter term problem. The demand is accelerating.
10:14 Speaker 03 We have about 10,000 boomers that are aging to 75 every day, and we expect that to continue through at least 2030, if not longer. So again, great news. But I think the biggest problem in our industry now is demand is going to dramatically outpace the supply of facilities, really over the next three, five, potentially even seven years unless construction ramps up. And before it does, occupancy obviously is expected to rise, right? So we see this metric that we're all watching. It's going from 88 to 90 to 92,
10:54 Speaker 03 95. There's certainly more patients coming in. But again, the supply is one of the biggest issues I think our industry is facing.
11:05 Speaker 02 Yeah, there's some things that we're seeing a dynamic in community pharmacy starting to expand services to their their home base client, their home base patient that has probably been using that community pharmacy forever. And the rise of long-term care at home pharmacy services, I think that will also expand. And I think there's going to be a blend between the, you know, the two environments of pharmacy services. And education coming from both of those sides is important to the public to let the public know, hey, these services are available. Technology plays a role. We're going to see more remote patient monitoring technology.
11:49 Speaker 02 We're going to see new APIs from the framework LTC systems, just like a recent announcement with the expansion of the technology through the launch of Framework Insights, which is a wonderful announcement that software writers got to make, that RXPR, our parent publishing company, got to be part of that press release, which is really cool. So I think that the the surge is going to open up opportunities for long-term care pharmacies to stick out and be very competitive in the markets. But back to some of, you know, what you're kind of giving us some preface and premonition,
12:31 Speaker 02 what's the outlook for the long-term care industry and how should investors and operators be watching interest rate policies?
12:39 Speaker 03 Yeah, you may have seen, you may have not, I follow it quite closely, but some of the indicators as to whether there's going to be a rate cut was just released this morning, so CPI. And the good news is that the the probability of a rate cut in the September meeting with the Fed is is sitting at about 89%. I just read that from JP Morgan yesterday. But if you think about the current environment, we do have high rates, we have a constrained housing market, and because of those rates, we have high borrowing costs, right? If you go and look at a mortgage or a refinance, it's it's very expensive for most people.
13:22 Speaker 03 So these variables have led to the less new facility construction. And further, that lower supply has really led to, as I mentioned, higher entrance fees. And while I think that's appropriate, right, we've been in a very inflationary environment. It makes it harder for seniors to move in, right? It's more expensive for them to move in, especially when their equity is locked into their homes. And it's difficult to sell in this sluggish market because people aren't wanting to enter into high interest rate mortgages. So this is where I'm starting to tie all these variables together. And you might see why interest rates are playing a role. And I was looking at some housing market data.
14:07 Speaker 03 And right now, it's one of the biggest gaps we've seen in history. There are over 500,000 more homes for sale or sellers than there are buyers right now. And that's very alarming, right? Either people are keeping their homes because they've locked in a 30 year mortgage at a couple points, right, 3%, 4%. They don't want to get rid of that. Prices are high. And then on the seller's side, there's also high mortgage rates. So here's where the unlocking really starts to happen. When interest rates are falling, mortgage rates will drop. It'll reignite the housing sales and unlock home liquidity for seniors. Now, what we believe is this is going to generate billions of dollars in capital for
14:49 Speaker 03 the boomers to cover those higher entrance fees. Billions of dollars that that will be unlocked, that someone will come in, right? It's going to be long term care facility revenue. So while we're not seeing the construction at the levels that we hope or need, someone is going to capitalize on that industry. And another source I look at. Welltower is one of the publicly traded REITs, so real estate investment trust. And they focus on the long-term care facility space. And I mean, they're up 40% in the last 12 months. I also look at a lot of their press releases and in some cases, join an earnings call and they're one of the big players in the space.
15:33 Speaker 03 And they're, it's clear they're doubling down and others will too. So with high entrance fees, lower cost of capital, I think investment in the long-term care facilities will become more compelling. This is that wave I mentioned, right? It's just going to start sort of tumbling down. And that will ultimately fuel growth for patients and for long-term care pharmacies.
15:57 Speaker 02 Yeah, a little earlier, I made a comment that ties into this ecosystem that Soft Riders is a part of in leading this long-term care pharmacy platform and technology, which their pharmacies, that's like the hub of everything, of the entire operations. So when I think of that and your perspective on our macro trends, that's perfect to kind of lead into this. But how do those trends connect the investments that Soft Riders are making into long-term care pharmacy technology? We went to your AI consortium that you had in Pittsburgh. We got to see everybody come together. We heard about some of the new functionality.
16:41 Speaker 02 You just released this brand new, you know, reporting system and analytics program called Framework Insight. So, you know, what's next? What's in your mind?
16:53 Speaker 03 Yeah, thanks for the plug for Insight. We've been very excited about that. That's our new BI solution and it's built on Tableau. So it's a very powerful visualization engine. And we've actually, I hired a few people on my FPNA team. They're Tableau experts.
17:13 Speaker 03 And we're not just trying to deploy this insight product at the pharmacies so they can ultimately customize and build all the reporting that they want, but we're using it internally for some of our our metrics, right? Making sure we we understand the ticket volume and what version of our software that's coming from, right? These all to make these insights internally all allow us to make decisions more quickly and turn to the parts of the business that need us. So, thank you for that. To answer your question, though, I think the trends we've been discussing, so occupancy rates, facility construction, there's still staffing pressures and demand for boomers are all directly linked to the operational realities
17:55 Speaker 03 of of the pharmacy. In our our customers, we hear this quite a bit, they're under enormous pressure to do more with less, right? They have fewer staff, tighter budgets, more residents needing medications. That's really why we're doubling down on this opportunity. We see that that wave that I mentioned and we're investing. So particularly, we talk about this at our user conference, we've sort of reframed that as our innovation conference, but we're very focused on AI, really as a way to dramatically improve efficiency and
18:35 Speaker 03 accuracy across all workflow processes and really the entire medication management process. So for us, we're investing tens of millions of dollars and ultimately dropping EBITDA margin, right? So we're not just taking profit, we're significantly reinvesting back into the business over the next several years to really build AI into our platform in a way that's strategic and impactful. And the way we've sort of approached it, right? This AI, I mean, it's been around here for, you know, 18 months, two years now, but integrating it into platforms and and companies, you know, putting a strategy around it, I think
19:17 Speaker 03 we've taken sort of a novel and really structured approach. So we map the entire journey of a script throughout our software.
19:26 Speaker 03 Really from intake to delivery and then came up with, you know, based on levels of automation, right? The first level is just decision support. So you have AI as sort of an assistant to help you make a decision and then sort of on the other spectrum, you have full automation, right? So we, we sort of created that metric and then came up with nearly a hundred different opportunities within our platform. And then we prioritize all of those and build what we called a risk, complexity and impact matrix. That really gave us a clear view of which AI features would deliver the largest benefit while balancing
20:10 Speaker 03 risk, right? Because obviously we deal in healthcare and there's clinical issues potentially if you apply AI to it. So we want to do it in a very, very safe way. So we're ensuring that our biggest investments target the biggest problems first. And over time, I think these AI capabilities will, will really drive deep automation and free up pharmacy staff to work on higher value, more patient centered work.
20:38 Speaker 02 Yeah, the map is really playing out because I remember hearing from the marketing team and even Scott, when, when I got to be part of one of your marketing events, that the purposeful of bringing clients together, bringing framework LTC users together to mind share how AI could truly impact patient care and effectiveness and operational efficiency. Then you took all of that mind share and you guys have staged and you prepared and you're, you're investing back into the product and back into the ability to leverage AI. It's brilliant because it's really setting up a success factor so that we can prepare
21:23 Speaker 02 for the surge in the demographic population and baby boomers and positioning long-term care pharmacies as staples and, and even the realm of PBM reform where
21:35 Speaker 02 Our politicians can see how effective these organizations are that are really impacting public health. And I think that this is a full ecosystem that you're part of and that we're part of. And I love this. And I think that, you know, I wonder, you know, what that roadmap really means. During that AI gathering of Framework LTC teams happened in Pittsburgh, we were able to say, hey, what's a real world example? So give us that. How's it going to change? How will this continue? This AI roadmap continue to change day-to-day work of our long-term care pharmacies?
22:14 Speaker 03 Yeah, I mean, right, I'm sure a lot of listeners are customers. So imagine, you know, prescription entering Framework LTC. I think today there are just a lot of manual checkpoints, right? Our software, like you mentioned in the introduction, it's workflow software, right? So there are a lot of manual steps from data entry, prior auth, clinical verification, the packaging and toting, the delivery. I think with our AI roadmap in place, I think you'll see many of those steps become either partially or fully automated.
22:58 Speaker 03 But we have been, you know, taking this movement incredibly seriously, and we just believe that the impact is massive, right? Reduced turnaround time, fewer errors, better compliance, significant time from staff freedom, not entering an order, right? We're starting with order entry to automate some of that work that comes into the pharmacy. And I think when scaled across thousands of prescriptions per day, the efficiency gains aren't just incremental, they can be transformative. And not just for the pharmacy or the facilities they serve. Also a better experience for the patient. Right. I think faster turnaround times.
23:43 Speaker 03 You even think about the the staff time savings that will be able to unlock. If you have bottlenecks in certain manual process steps within the pharmacy. And we're able to reduce those bottlenecks from, you know, the three minutes down to one minute. We actually significantly increase the capacity of a pharmacy to distribute more meds. Within the technology. So that's why we just think that this is going to be transformative. And we have some really bright minds that are that are building it within the software and a really safe and responsible way, which is really important for us as an organization.
24:26 Speaker 02 Yeah, I know that Soft Riders has been part of NC PDP to help kind of write the standards and write the script of what's best information to be exchanging.
24:38 Speaker 02 Shout out to Shelley Spyro. I mean, wow, she what a legend to kind of help to have started that way, way back in the day. Making me actually feel old. I can start saying stuff like that, Jason.
24:49 Speaker 03 I'm in the same boat.
24:52 Speaker 02 But I I'm wondering, you know, AI is a buzzword. There's lots of people that throw that around. Where do you see Soft Riders from a perspective that you're keeping your eyes on markets, you're keeping your eyes on financial players who are obviously involved with artificial intelligence to crunch data and build out predictive models and do all of this stuff. So what's what's the approach that Soft Riders is taking that that you see is different?
25:21 Speaker 03 Yeah, I think I don't recall the stats off the top of my head, but Scott, our president and I. I think it was just two or three weeks ago, we went to the SCPC meeting. And Scott had the privilege of presenting on AI. And one of the stats we found was how much investment is going into AI today? And then comparing that to how much investment was going into the Internet whenever the Internet came to be.
25:53 Speaker 03 And AI is like tenfold. I mean, it's just tremendous amounts of capital that are that are going into it. And we're we're starting to see, you know, these, I call them startups, right? Because they're, AI is new, they want to be an AI first company, they're they're building AI. And they're coming into the industry and and trying to build sort of point solutions, right? So here's a problem, we want to automate it. I think that's, you know, certainly a business model if if a company chooses to do that. But I think our difference is really in a very intentional scope, a very intentional prioritization. And I think most importantly, integration. Integration is critical.
26:35 Speaker 03 And I think that we're the most equipped to build an integrated AI suite across all of our products. And I mentioned the nearly 100 different AI initiatives, which span nearly every major workflow. And we're we're sort of sequencing them based on that risk complexity and and impact matrix. I mentioned, but that means we're not just chasing shiny objects. We're delivering what matters most in a responsible and safe way. And then I'd say lastly, because of our our software already powers a large proportion of the long term care pharmacy market. And happy to say that continues to grow.
27:18 Speaker 03 We continue to to gain penetration in the space year over year. I think we can deliver these AI capabilities at scale. And I think it gives us the ability to create efficiencies that more or less ripple through the entire LTC ecosystem. And I think that's what has the teams most excited is our, you know, our mission of empower LTC pharmacies, save lives, and ultimately, you know, making what we do best even better to ultimately allow the network of pharmacies that are our customers to scale through this wave of growth that I expect in the next, you know, five, 10 years. So we're really excited about it.
28:03 Speaker 02 We're excited to hear about it, especially from that perspective. And if you want to hear more about the innovation of long-term care pharmacy, the Framework LTC Innovation Conference is coming very soon. It's going to be September 15th through 17th, 2025. You can go to frameworkltc.vfairs.com. That's frameworkltc.vfairs.com. Or don't worry, it'll be in the show notes. There'll be a link to going to the registration, meeting everybody in beautiful San Diego,
28:42 Speaker 02 California, and coming together for the 15th Annual Framework LTC Innovation Conference. Do you have a speaking slot in there, Jason, that you're going to be sharing some stuff with us?
28:54 Speaker 03 I do, yeah. Last year, I had the pleasure of introducing some of the AI BI work that BI is our insight product. So it was great to be able to sort of launch that, let the industry know what we're working on and what's coming. That's since launched, and I'll be speaking at the beginning, talking a little bit more on AI and what we're doing there.
29:18 Speaker 02 I love it. I'm excited. All right. All right. I have to end with this. It's football season, so what's going on in your head? Where are you, a Steeler fan now? Are you not a Steeler fan? Like, what's happening?
29:31 Speaker 03 Yeah, I'm born and raised in Pittsburgh, so one of my passions is traveling. I've been to, I think I'm at 39 countries, and I want to get to my 40th. But for some reason, I just love this city. You know, you have to be true to the sports teams. One interesting fact is we're the only city where all of our teams are black and gold. So not everyone knows that. It's black and gold for our Pirates, Penguins, and Steelers.
29:58 Speaker 02 Yeah, and my accent color too.
30:01 Speaker 03 Yeah, there you go. There's the goal.
30:03 Speaker 02 On purpose. Hey, this has been a wonderful episode, down to earth and really insightful episode of Framework Focus. We're excited that Framework is continuing to expand. If you'd like to subscribe to Framework Focus, we are on Apple, Spotify, Amazon, anywhere that they publish podcasts, you can find Framework Focus. And if you would like to learn more, please check out frameworkltc.com. Once again, that's frameworkltc.com. Jason, this has been wonderful. Thank you so much for sharing your insights.
30:41 Speaker 03 Great. Thank you so much, Todd. Really appreciate the time and thanks to all the listeners for tuning in.
Previous Radiant Skincare From Seed to Bottle with Aviva Tilson | Holistic Pharmacy Podcast Next Bringing You Outcomes at ThoughtSpot 2025 | ThoughtSpot Recap Part One Page updated November 15, 2026 · transcript and summary are machine-generated